Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tavan Janvilisri

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 18

Top Venues

Pharmaceuticals (Basel, Switzerland)

Disease markers

Cancers

Antibiotics (Basel, Switzerland)

Mahidol University Faculty of Science

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mahidol University Faculty of Science Oct 1o 2011

Thailand

Associate Professor :: Biochemistry

Education History

University of Cambridge Oct 1o 2001 - Sep 30o 2004

United Kingdom

PHD :: Pharmacology

Publications

Supitchaya Pantia, Thaned Kangsamaksin, Tavan Janvilisri, Waraporn Komyod
Asiatic Acid Inhibits Nasopharyngeal Carcinoma Cell Viability and Migration via Suppressing STAT3 and Claudin-1. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Supitchaya Pantia, Thaned Kangsamaksin, Tavan Janvilisri, Waraporn Komyod
Asiatic Acid Inhibits Nasopharyngeal Carcinoma Cell Viability and Migration via Suppressing STAT3 and Claudin-1. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, Kyaw Zwar Myint, Jitlada Juengsamarn, Poowanai Sarkhampee, Nithi Lertsawatvicha, Jittiyawadee Sripa, Thiti Kuakpaetoon, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Anna M Grabowska, David Owen Bates, Tavan Janvilisri, Rutaiwan Tohtong
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma. Cancers 15 (9) (2023)
Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, Kyaw Zwar Myint, Jitlada Juengsamarn, Poowanai Sarkhampee, Nithi Lertsawatvicha, Jittiyawadee Sripa, Thiti Kuakpaetoon, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Anna M Grabowska, David Owen Bates, Tavan Janvilisri, Rutaiwan Tohtong
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma. Cancers 15 (9) (2023)
Supapit Wongkuna, Tavan Janvilisri, Matthew Phanchana, Phurt Harnvoravongchai, Amornrat Aroonnual, Sathid Aimjongjun, Natamon Malaisri, Surang Chankhamhaengdecha
Temporal Variations in Patterns of Clostridioides difficile Strain Diversity and Antibiotic Resistance in Thailand. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Pichamon Kiatwuthinon, Thana Narkthong, Utapin Ngaokrajang, Supeecha Kumkate, Tavan Janvilisri
Baicalein Inhibits Metastatic Phenotypes in Nasopharyngeal Carcinoma Cells via a Focal Adhesion Protein Integrin β8. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Thanawat Sridapan, Wanida Tangkawsakul, Tavan Janvilisri, Taradon Luangtongkum, Wansika Kiatpathomchai, Surang Chankhamhaengdecha
Rapid and simultaneous detection of Campylobacter spp. and Salmonella spp. in chicken samples by duplex loop-mediated isothermal amplification coupled with a lateral flow biosensor assay. PloS one 16 (7) (2021)
Supapit Wongkuna, Sudeep Ghimire, Surang Chankhamhaengdecha, Tavan Janvilisri, Joy Scaria
Mediterraneibacter catenae SW178 sp. nov., an intestinal bacterium of feral chicken. PeerJ 9 (2021)
Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Tavan Janvilisri, Kanokpan Wongprasert, Supeecha Kumkate, David O Bates, Rutaiwan Tohtong
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma. Pharmaceuticals (Basel, Switzerland) 14 (1) (2021)
Chawalit Ngernsombat, Pongphol Prattapong, Noppadol Larbcharoensub, Krittika Khotthong, Tavan Janvilisri
WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma. Current oncology (Toronto, Ont.) 28 (4) (2021)
Brinda Balasubramanian, Simran Venkatraman, Tavan Janvilisri, Tuangporn Suthiphongchai, Siriporn Jitkaew, Jittiyawadee Sripa, Rutaiwan Tohtong
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Suvash Chandra Ojha, Matthew Phanchana, Phurt Harnvoravongchai, Surang Chankhamhaengdecha, Sombat Singhakaew, Puey Ounjai, Tavan Janvilisri
Teicoplanin Suppresses Vegetative Clostridioides difficile and Spore Outgrowth. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Timmy Richardo, Pongphol Prattapong, Chawalit Ngernsombat, Nurulfitri Wisetyaningsih, Hisashi Iizasa, Hironori Yoshiyama, Tavan Janvilisri
Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis. Cancers 12 (9) (2020)
Pongphol Prattapong, Chawalit Ngernsombat, Sathid Aimjongjun, Tavan Janvilisri
CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line. Cancer reports (Hoboken, N.J.) 3 (2) (2019)
Chawalit Ngernsombat, Suthasinee Sreesai, Phurt Harnvoravongchai, Surang Chankhamhaengdecha, Tavan Janvilisri
CD2068 potentially mediates multidrug efflux in Clostridium difficile. Scientific reports 7 (1) (2017)
Tavan Janvilisri, Kawin Leelawat, Sittiruk Roytrakul, Atchara Paemanee, Rutaiwan Tohtong
Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. Disease markers 2015 (2015)
Tavan Janvilisri, Haruo Suzuki, Joy Scaria, Jenn-Wei Chen, Varodom Charoensawan
High-Throughput Screening for Biomarker Discovery. Disease markers 2015 (2015)
Tavan Janvilisri
Omics-based identification of biomarkers for nasopharyngeal carcinoma. Disease markers 2015 (2015)

Tavan Janvilisri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tavan Janvilisri